SPONSOR
Sir Run Run Shaw Hospital
Total Trials
4
Recruiting
4
Phases
EARLY_Phase 1, Phase 2
Sir Run Run Shaw Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Colorectal Cancer, Hepatoma Resectable, Stroke, Acute Ischemic, Rectal Adenocarcinoma.
The trial portfolio spans EARLY_Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sir Run Run Shaw Hospital
How many clinical trials has Sir Run Run Shaw Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Sir Run Run Shaw Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Colorectal Cancer, Hepatoma Resectable, Stroke, Acute Ischemic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sir Run Run Shaw Hospital research focus on?
Sir Run Run Shaw Hospital clinical trials span Colorectal Cancer, Hepatoma Resectable, Stroke, Acute Ischemic, Rectal Adenocarcinoma. The research pipeline includes EARLY_Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sir Run Run Shaw Hospital clinical trial?
To participate in a Sir Run Run Shaw Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sir Run Run Shaw Hospital trials with current recruitment status updated daily.
Clinical Trials by Sir Run Run Shaw Hospital
NCT06167967
Recruiting
Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer
Colorectal Cancer
NCT05035108 EARLY_Phase 1
Recruiting
The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy
Hepatoma Resectable
NCT07016854
Recruiting
Early Endovascular Treatment in Isolated Internal Carotid Artery Occlusion
Stroke, Acute Ischemic
NCT06266832 Phase 2
Recruiting
The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma
Rectal Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology